These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 33292227)

  • 1. Correction to: Regional disparities in the flow of access to breast cancer hospitalizations in Brazil in 2004 and 2014.
    de Souza BC; Dos Santos Figueiredo FW; de Alcantara Sousa LV; da Silva Maciel E; Adami F
    BMC Womens Health; 2020 Dec; 20(1):270. PubMed ID: 33292227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correction to: Assessing inequalities and regional disparities in child nutrition outcomes in India using MANUSH - a more sensitive yardstick.
    Jain A; Agnihotri SB
    Int J Equity Health; 2020 Oct; 19(1):176. PubMed ID: 33028321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correction to: microRNA-124 inhibits bone metastasis of breast cancer by repressing Interleukin-11.
    Cai WL; Huang WD; Li B; Chen TR; Li ZX; Zhao CL; Li HY; Wu YM; Yan WJ; Xiao JR
    Mol Cancer; 2020 Jun; 19(1):111. PubMed ID: 32593305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correction to: The efficacy of etanercept as anti-breast cancer treatment is attenuated by residing macrophages.
    Shirmohammadi E; Ebrahimi SS; Farshchi A; Salimi M
    BMC Cancer; 2020 Nov; 20(1):1126. PubMed ID: 33218315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correction to: LINC00673 is activated by YY1 and promotes the proliferation of breast cancer cells via the miR-515-5p/MARK4/Hippo signaling pathway.
    Qiao K; Ning S; Wan L; Wu H; Wang Q; Zhang X; Xu S; Pang D
    J Exp Clin Cancer Res; 2020 Aug; 39(1):154. PubMed ID: 32782003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correction to: A window-of-opportunity trial of the CXCR1/2 inhibitor reparixin in operable HER-2-negative breast cancer.
    Goldstein LJ; Perez RP; Yardley D; Han LK; Reuben JM; Gao H; McCanna S; Butler B; Ruffini PA; Liu Y; Rosato RR; Chang JC
    Breast Cancer Res; 2020 May; 22(1):52. PubMed ID: 32434589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correction to: Prognostic biomarkers related to breast cancer recurrence identified based on Logit model analysis.
    Zhou X; Xiao C; Han T; Qiu S; Wang M; Chu J; Sun W; Li L; Lin L
    World J Surg Oncol; 2020 Dec; 18(1):320. PubMed ID: 33278881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correction to: Relationship of objectively measured physical activity and sedentary behaviour with health-related quality of life among breast cancer survivors.
    Nurnazahiah A; Shahril MR; Syamimi ZN; Ahmad A; Sulaiman S; Lua PL
    Health Qual Life Outcomes; 2020 Aug; 18(1):259. PubMed ID: 32762686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correction to: Cost-effectiveness of a tailored intervention designed to increase breast cancer screening among a non-adherent population: a randomized controlled trial.
    Ishikawa Y; Hirai K; Saito H; Fukuyoshi J; Yonekura A; Harada K; Seki A; Shibuya D; Nakamura Y
    BMC Public Health; 2020 Nov; 20(1):1731. PubMed ID: 33198694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correction to: Best MRI sequences for identifying axillary lymph node markers in patients with metastatic breast cancer: an inter-reader observational study.
    Samreen N; Bhatt AA; Adler K; Zingula S; Glazebrook KN
    Eur Radiol Exp; 2020 Aug; 4(1):53. PubMed ID: 32809078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correction to: Trastuzumab-induced upregulation of a protein set in extracellular vesicles emitted by ErbB2-positive breast cancer cells correlates with their trastuzumab sensitivity.
    Drucker A; Yoo BH; Khan IA; Choi D; Montermini L; Liu X; Jovanovic S; Younis T; Rosen KV
    Breast Cancer Res; 2020 Oct; 22(1):110. PubMed ID: 33092601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correction to: Induction of immunogenic cell death in radiation-resistant breast cancer stem cells by repurposing anti-alcoholism drug disulfiram.
    Sun T; Yang W; Toprani SM; Guo W; He L; DeLeo AB; Ferrone S; Zhang G; Wang E; Lin Z; Hu P; Wang X
    Cell Commun Signal; 2020 Apr; 18(1):53. PubMed ID: 32241283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correction to: Platelets promote breast cancer cell MCF-7 metastasis by direct interaction: surface integrin α2β1-contacting-mediated activation of Wnt-β-catenin pathway.
    Zuo XX; Yang Y; Zhang Y; Zhang ZG; Wang XF; Shi YG
    Cell Commun Signal; 2020 Aug; 18(1):125. PubMed ID: 32791976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correction to: Impact of a combined multimodal-aerobic and multimodal intervention compared to standard aerobic treatment in breast cancer survivors with chronic cancer-related fatigue - results of a three-armed pragmatic trial in a comprehensive cohort design.
    Kröz M; Reif M; Glinz A; Berger B; Nikolaou A; Zerm R; Brinkhaus B; Girke M; Büssing A; Gutenbrunner C;
    BMC Cancer; 2020 Dec; 20(1):1174. PubMed ID: 33261571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correction to: Effect of PEEP decremental on respiratory mechanics, gas exchange, pulmonary regional ventilation, and hemodynamics in patients with SARS-Cov-2-associated Acute Respiratory Distress Syndrome.
    Bonny V; Janiak V; Spadaro S; Pinna A; Demoule A; Dres M
    Crit Care; 2020 Dec; 24(1):675. PubMed ID: 33276801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Publisher Correction: Cancer disparities in war-torn and post-war regions.
    Mired D; Johnson S; Tamamyan G
    Nat Rev Cancer; 2020 Jul; 20(7):412. PubMed ID: 32528184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correction to: The majority of β-catenin mutations in colorectal cancer is homozygous.
    Arnold A; Tronser M; Sers C; Ahadova A; Endris V; Mamlouk S; Horst D; Möbs M; Bischoff P; Kloor M; Bläker H
    BMC Cancer; 2020 Nov; 20(1):1151. PubMed ID: 33243186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correction to: Outcome quality standards in advanced ovarian cancer surgery.
    Llueca A; Serra A; Climent MT; Segarra B; Maazouzi Y; Soriano M; Escrig J;
    World J Surg Oncol; 2020 Dec; 18(1):323. PubMed ID: 33287840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correction to: Assessment of choriocapillary blood flow changes in response to half-dose photodynamic therapy in chronic central serous chorioretinopathy using optical coherence tomography angiography.
    Liu J; Chen C; Li L; Xu Y; Yi Z; He L; Zheng H
    BMC Ophthalmol; 2020 Nov; 20(1):445. PubMed ID: 33183259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correction to: Musashi2 promotes EGF-induced EMT in pancreatic cancer via ZEB1-ERK/MAPK signaling.
    Sheng W; Shi X; Lin Y; Tang J; Jia C; Cao R; Sun J; Wang G; Zhou L; Dong M
    J Exp Clin Cancer Res; 2020 Aug; 39(1):167. PubMed ID: 32838790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.